{
    "title": "Eisai-Biogen Alzheimer's drug data confirms benefits, FDA staff says",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12170251/FDA-staff-say-Eisais-Alzheimers-drug-approval-despite-safety-concerns.html",
    "date": "2023-06-07",
    "keywords": [
        "drug",
        "approval",
        "leqembi",
        "staff",
        "trial",
        "condition",
        "coverage",
        "leo",
        "mandowara",
        "panel",
        "friday",
        "application",
        "use",
        "blood",
        "risk",
        "brain",
        "extension",
        "medicare",
        "reporting",
        "june",
        "food",
        "administration",
        "wednesday",
        "eisai",
        "benefit",
        "safety",
        "meeting",
        "decision",
        "july",
        "vote",
        "capital",
        "analyst",
        "rate",
        "decline",
        "placebo",
        "hemorrhage",
        "part",
        "latestage",
        "prescribing",
        "information",
        "side",
        "amyloid",
        "angiopathy",
        "protein",
        "death",
        "patient",
        "association",
        "incident",
        "briefing",
        "biogen",
        "demand",
        "wider",
        "insurance",
        "plan",
        "health",
        "age",
        "january",
        "policy",
        "executive",
        "ivan",
        "cheung",
        "interview",
        "tuesday",
        "khushi",
        "julie",
        "steenhuysen",
        "chicago",
        "editing",
        "anil",
        "dsilva",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}